Novozymes A/S (OTCMKTS:NVZMY - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $59.69 and traded as low as $57.19. Novozymes A/S shares last traded at $59.31, with a volume of 96,785 shares changing hands.
Novozymes A/S Stock Performance
The firm's fifty day simple moving average is $58.46 and its 200-day simple moving average is $59.47. The stock has a market cap of $28.58 billion, a P/E ratio of 38.62, a price-to-earnings-growth ratio of 3.87 and a beta of 0.91.
Novozymes A/S Increases Dividend
The company also recently declared a dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Monday, April 7th will be given a dividend of $0.3758 per share. The ex-dividend date of this dividend is Monday, April 7th. This is a boost from Novozymes A/S's previous dividend of $0.17. Novozymes A/S's dividend payout ratio is 47.47%.
Novozymes A/S Company Profile
(
Get Free Report)
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Further Reading
Before you consider Novozymes A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.
While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.